Reported 45,283,000 shares, unchanged from the prior quarter.
Reported value 0.3%; share count 0.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-09-30 | 36679000 |
| 2021-12-31 | 36679000 |
| 2022-03-31 | 34302000 |
| 2022-06-30 | 34415000 |
| 2022-09-30 | 34415000 |
| 2022-12-31 | 34415000 |
| 2023-03-31 | 34415000 |
| 2023-06-30 | 36384891 |
| 2023-09-30 | 30905648 |
| 2023-12-31 | 31018855 |
| 2024-03-31 | 31018855 |
| 2024-06-30 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q2 2024 | Reduced | 0 | -45,283,000 (-100.0%) | 0 | $0 | 2024-08-12 | |
| Q1 2024 | Unchanged | 45,283,000 | 0 (0.0%) | 1.14% | $31,018,855 | 2024-05-10 | |
| Q4 2023 | Unchanged | 45,283,000 | 0 (0.0%) | 1.26% | $31,018,855 | 2024-02-12 | |
| Q3 2023 | Unchanged | 45,283,000 | 0 (0.0%) | 1.28% | $30,905,648 | 2023-11-13 | |
| Q2 2023 | Unchanged | 45,283,000 | 0 (0.0%) | 1.6% | $36,384,891 | 2023-08-11 | |
| Q1 2023 | Unchanged | 45,283,000 | 0 (0.0%) | 1.27% | $34,415,000 | 2023-05-11 | |
| Q4 2022 | Unchanged | 45,283,000 | 0 (0.0%) | 0.95% | $34,415,000 | 2023-02-13 | |
| Q3 2022 | Unchanged | 45,283,000 | 0 (0.0%) | 0.48% | $34,415,000 | 2022-11-14 | |
| Q2 2022 | Unchanged | 45,283,000 | 0 (0.0%) | 0.78% | $34,415,000 | 2022-08-11 | |
| Q1 2022 | Unchanged | 45,283,000 | 0 (0.0%) | 0.8% | $34,302,000 | 2022-05-11 | |
| Q4 2021 | Unchanged | 45,283,000 | 0 (0.0%) | 0.8% | $36,679,000 | 2022-02-11 | |
| Q3 2021 | Reduced | 45,283,000 | -2,500,000 (-5.2%) | 0.97% | $36,679,000 | 2021-11-12 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
10 managers reported ACORDA THERAPEUTICS INC for Q2 2022.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| Davidson Kempner Capital Management LP | Unchanged | 0 | 0 | 0.66% | $38,202,000 | 6 qtrs |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC This report | Unchanged | 45,283,000 | 0 | 0.78% | $34,415,000 | 6 qtrs |
| UBS OCONNOR LLC | Unchanged | 30,000,000 | 0 | 0.23% | $22,523,000 | 6 qtrs |
| CANYON CAPITAL ADVISORS LLC | Unchanged | 25,875,000 | 0 | 1.51% | $19,021,000 | 6 qtrs |
| SOROS FUND MANAGEMENT LLC | Unchanged | 28,001,000 | 0 | 0.29% | $16,213,000 | 6 qtrs |
| D E Shaw & Co Inc | Unchanged | 14,000,000 | 0 | 0.01% | $10,435,000 | 6 qtrs |
| WELLS FARGO & COMPANY MN | Unchanged | 5,018,000 | 0 | < 0.01% | $3,814,000 | 6 qtrs |
| Saltoro Capital LP | Unchanged | 1,500,000 | 0 | 0.27% | $1,110,000 | 6 qtrs |
| Jefferies Group LLC | Reduced | 0 | -2,000,000 | 0 | $0 | 6 qtrs |
| CONCOURSE FINANCIAL GROUP SECURITIES INC | Unchanged | 0 | 0 | 0 | $0 | 6 qtrs |
Filing details and methodology As reported
- Report period
- June 30, 2022
- Filed
- August 11, 2022
- Filing type
- 13F-HR
- Position type
- BOND
Voting authority reported
- Sole
- 0
- Shared
- 45,283,000
- None
- 0
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.